This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Carasent Past Earnings Performance

Past criteria checks 0/6

Carasent's earnings have been declining at an average annual rate of -16.6%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 33.6% per year.

Key information

-16.6%

Earnings growth rate

-8.9%

EPS growth rate

Healthcare Services Industry Growth12.5%
Revenue growth rate33.6%
Return on equity-0.8%
Net Margin-3.0%
Next Earnings Update13 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Carasent makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0H9M Revenue, expenses and earnings (NOK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24265-81570
30 Jun 24254-101480
31 Mar 24251-561500
31 Dec 23244-461460
30 Sep 23235-641170
30 Jun 23227-491060
31 Mar 232105840
31 Dec 2219531650
30 Sep 2217947980
30 Jun 2216815870
31 Mar 2215433750
31 Dec 211370620
30 Sep 21117-33990
30 Jun 2198-21890
31 Mar 2183-46800
31 Dec 2071-38730
30 Sep 2064-14260
30 Jun 2058-4240
31 Mar 20523230
31 Dec 19483220
30 Sep 19442200
30 Jun 19400190
31 Mar 1935-3180
31 Dec 1824-7150
30 Sep 181412160
30 Jun 18618120
31 Mar 1801970
31 Dec 1702060
30 Sep 1725128-280
30 Jun 1779131-40
31 Mar 17136139220
31 Dec 16194142500
30 Sep 162053100
30 Jun 1623456510
31 Mar 1625956690
31 Dec 1530561940
30 Sep 15322-311310
30 Jun 15307-801000
31 Mar 15314-841000
31 Dec 14294-79910
30 Sep 142552640
30 Jun 142482630
31 Mar 142463660
31 Dec 132545720

Quality Earnings: 0H9M is currently unprofitable.

Growing Profit Margin: 0H9M is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0H9M is unprofitable, and losses have increased over the past 5 years at a rate of 16.6% per year.

Accelerating Growth: Unable to compare 0H9M's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0H9M is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (14.4%).


Return on Equity

High ROE: 0H9M has a negative Return on Equity (-0.84%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/05 02:48
End of Day Share Price 2024/11/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Carasent AB (publ) is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Commissioned Research
Ole-Andreas KrohnDNB Markets
Christoffer BjørnsenDNB Markets